Protein S-nitrosylation in preconditioning and postconditioning

Experimental Biology and Medicine

Volumn 239, Issue 6, 2014, Pages 647-662

  Penna, Claudia ^a   Angotti, Carmelina ^a   Pagliaro, Pasquale ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

cardioprotection; ischemia; Nitration; nitrosation; nitrosative signaling; reperfusion

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CARBONYL REDUCTASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GUANYLATE CYCLASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; S NITROSOTHIOL; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN 1; THIOREDOXIN 2; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHINE OXIDASE; NITRIC OXIDE;

ARTICLE; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MORBIDITY; NITRATION; NITROSATION; NITROSATIVE STRESS; NITROSYLATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN LOCALIZATION; PROTEIN S NITROSYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REPERFUSION INJURY; STUNNED HEART MUSCLE; ANIMAL; HEART INFARCTION PREVENTION; METABOLISM; PATHOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; CORONARY ARTERY DISEASE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; NITRIC OXIDE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84903384952     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214522935     Document Type: Article

References (212)

1. Zweier JL,Samouilov A,Kuppusamy P.Non-enzymatic nitric oxide synthesis in biological systems.Biochim Biophys Acta. 1999;1411:250-62.
2. Zweier JL,Li H,Samouilov A,Liu X.Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall.Nitric Oxide. 2010;22:83-90.
3. Trujillo M,Alvarez MN,Peluffo G,Freeman BA,Radi R.Xanthine oxidase-mediated decomposition of S-nitrosothiols.J Biol Chem. 1998;273:7828-34.
4. Lim G,Venetucci L,Eisner DA,Casadei B.Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling.Cardiovasc Res. 2008;77:256-64.
5. Zhang YH,Casadei B.Sub-cellular targeting of constitutive NOs in health and disease.J Mol Cell Cardiol. 2012;52:341-50.
6. Stuehr DJ.Mammalian nitric oxide synthases.Biochim Biophys Acta. 1999;1411:217-30.
7. Xia C,Misra I,Iyanagi T,Kim JJ.Regulation of interdomain interactions by calmodulin in inducible nitric-oxide synthase.J Biol Chem. 2009;284:30708-17.
8. Zaobornyj T,Ghafourifar P.Strategic localization of heart mitochondrial NOS: a review of the evidence.Am J Physiol Heart Circ Physiol. 2012;303:H1283-93.
9. Sun J,Murphy E.Protein S-nitrosylation and cardioprotection.Circ Res. 2010;106:285-96.
10. Pagliaro P,Moro F,Tullio F,Perrelli MG,Penna C.Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling.Antioxid Redox Signal. 2011;14:833-50.
11. Brady NR,Hamacher-Brady A,Westerhoff HV,Gottlieb RA.A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria.Antioxid Redox Signal. 2006;8:1651-65.
12. Baines CP.The mitochondrial permeability transition pore as a target of cardioprotective signaling.Am J Physiol Heart Circ Physiol. 2007;293:H903-4.
13. Costa AD,Garlid KD.Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT.Am J Physiol Heart Circ Physiol. 2008;295:H874-82.
14. Dost T,Cohen MV,Downey JM.Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning.Basic Res Cardiol. 2008;103:378-84.
15. Brown DI,Griendling KK.Nox proteins in signal transduction.Free Radic Biol Med. 2009;47:1239-53.
16. Chen K,Craige SE,Keaney JF.Downstream targets and intracellular compartmentalization in Nox signaling.Antioxid Redox Signal. 2009;11:2467-80.
17. Garlid AO,Jaburek M,Jacobs JP,Garlid KD.Mitochondrial reactive oxygen species - Which ROS signals cardioprotection?.Am J Physiol Heart Circ Physiol. 2013;305:H960-8.
18. Martinez-Ruiz A,Araujo IM,Izquierdo-Alvarez A,Hernansanz-Agustin P,Lamas S,Serrador JM.Specificity in S-Nitrosylation: a short-range mechanism for NO signaling?.Antioxid Redox Signal. 2013;19: 1220-35.
19. Murry CE,Jennings RB,Reimer KA.Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation. 1986;74:1124-36.
20. Pagliaro P,Gattullo D,Rastaldo R,Losano G.Ischemic preconditioning: from the first to the second window of protection.Life Sci. 2001;69:1-15.
21. Zhao ZQ,Corvera JS,Halkos ME,Kerendi F,Wang NP,Guyton RA,Vinten-Johansen J.Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.Am J Physiol Heart Circ Physiol. 2003;285:H579-88.
22. Skyschally A,Van Caster P,Iliodromitis EK,Schulz R,Kremastinos DT,Heusch G.Ischemic postconditioning: experimental models and protocol algorithms.Basic Res Cardiol. 2009;104:469-83.
23. Yellon DM,Downey JM.Preconditioning the myocardium: from cellular physiology to clinical cardiology.Physiol Rev. 2003;83:1113-51.
24. Schulz R,Kelm M,Heusch G.Nitric oxide in myocardial ischemia/reperfusion injury.Cardiovasc Res. 2004;61:402-13.
25. Boengler K,Heusch G,Schulz R.Mitochondria in postconditioning.Antioxid Redox Signal. 2011;14:863-80.
26. Cohen MV,Downey JM.Ischemic postconditioning: from receptor to end-effector.Antioxid Redox Signal. 2011;14:821-31.
27. Hausenloy DJ,Lecour S,Yellon DM.Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin.Antioxid Redox Signal. 2011;14:893-907.
28. Nakamura T,Lipton SA.S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.Antioxid Redox Signal. 2011;14:1479-92.
29. Brown GC,Borutaite V.Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols.Biochim Biophys Acta. 2004;1658:44-9.
30. Titheradge MA.Nitric oxide in septic shock.Biochim Biophys Acta. 1999;1411:437-55.
31. Santhanam L,Lim HK,Lim HK,Miriel V,Brown T,Patel M,Balanson S,Ryoo S,Anderson M,Irani K,Khanday F,Di Costanzo L,Nyhan D,Hare JM,Christianson DW,Rivers R,Shoukas A,Berkowitz DE.Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction.Circ Res. 2007;101:692-702.
32. Sips PY,Irie T,Zou L,Shinozaki S,Sakai M,Shimizu N,Nguyen R,Stamler JS,Chao W,Kaneki M,Ichinose F.Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression.Am J Physiol Heart Circ Physiol. 2013;304:H1134-46.
33. Jones SP,Bolli R.The ubiquitous role of nitric oxide in cardioprotection.J Mol Cell Cardiol. 2006;40:16-23.
34. Atar S,Ye Y,Lin Y,Freeberg SY,Nishi SP,Rosanio S,Huang MH,Uretsky BF,Perez-Polo JR,Birnbaum Y.Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.Am J Physiol Heart Circ Physiol. 2006;290:H1960-8.
35. Hausenloy DJ,Yellon DM.The second window of preconditioning (SWOP) where are we now?.Cardiovasc Drugs Ther. 2010;24:235-54.
36. Bolli R.The late phase of preconditioning.Circ Res. 2000;87:972-83.
37. Bolli R,Dawn B,Tang XL,Qiu Y,Ping P,Xuan YT,Jones WK,Takano H,Guo Y,Zhang J.The nitric oxide hypothesis of late preconditioning.Basic Res Cardiol. 1998;93:325-38.
38. Espey MG,Miranda KM,Thomas DD,Xavier S,Citrin D,Vitek MP,Wink DA.A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species.Ann N Y Acad Sci. 2002;962:195-206.
39. Simon DI,Mullins ME,Jia L,Gaston B,Singel DJ,Stamler JS.Polynitrosylated proteins: characterization, bioactivity, and functional consequences.Proc Natl Acad Sci USA. 1996;93:4736-41.
40. Zhang YY,Xu AM,Nomen M,Walsh M,Keaney JF,Loscalzo J.Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides.Biochemical characterization and bioactivity. J Biol Chem. 1996;271:14271-9.
41. Wink DA,Darbyshire JF,Nims RW,Saavedra JE,Ford PC.Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction.Chem Res Toxicol. 1993;6:23-7.
42. Zou M,Martin C,Ullrich V.Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite.Biol Chem. 1997;378:707-13.
43. Turko IV,Murad F.Protein nitration in cardiovascular diseases.Pharmacol Rev. 2002;54:619-34.
44. Ischiropoulos H.Biological selectivity and functional aspects of protein tyrosine nitration.Biochem Biophys Res Commun. 2003;305:776-83.
45. Kupai K,Csonka C,Fekete V,Odendaal L,van Rooyen J,Marais de W,Csont T,Ferdinandy P.Cholesterol diet induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite.Am J Physiol Heart Circ Physiol. 2009;297:H1729-35.
46. Li J,Loukili N,Rosenblatt-Velin N,Pacher P,Feihl F,Waeber B,Liaudet L.Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.PLoS One. 2013;8:e70-e70.
47. Penna C,Perrelli MG,Tullio F,Moro F,Parisella ML,Merlino A,Pagliaro P.Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation.Pflugers Arch. 2011;462:219-33.
48. Yang YY,Lee KC,Huang YT,Wang YW,Hou MC,Lee FY,Lin HC,Lee SD.Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.J Hepatol. 2008;49:25-33.
49. Inserte J,Hernando V,Vilardosa Ú,Abad E,Poncelas-Nozal M,Garcia-Dorado D.Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.J Am Heart Assoc. 2013;2:e005975-e005975.
50. Stamler JS,Toone EJ.The decomposition of thionitrites.Curr Opin Chem Biol. 2002;6:779-85.
51. Hou Y,Guo Z,Li J,Wang PG.Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols.Biochem Biophys Res Commun. 1996;228:88-93.
52. Grisham MB.Effect of superoxide dismutase on the stability of S-nitrosothiols.Arch Biochem Biophys. 1999;361:323-30.
53. Jourd'heuil D,Laroux FS,Miles AM,Wink DA,Grisham MB.Effect of superoxide dismutase on the stability of S-nitrosothiols.Arch Biochem Biophys. 1999;361:323-30.
54. Sliskovic I,Raturi A,Mutus B.Characterization of the S-denitrosation activity of protein disulfide isomerase.J Biol Chem. 2005;280:8733-41.
55. Bateman RL,Rauh D,Tavshanjian B,Shokat KM.Human carbonyl reductase 1 is an S-nitrosoglutathione reductase.J Biol Chem. 2008;283:35756-62.
56. Benhar M,Forrester MT,Hess DT,Stamler JS.Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins.Science. 2008;320:1050-54.
57. Anand P,Stamler JS.Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.J Mol Med (Berl). 2012;90:233-44.
58. Beigi F,Gonzalez DR,Minhas KM,Sun QA,Foster MW,Khan SA,Treuer AV,Dulce RA,Harrison RW,Saraiva RM,Premer C,Schulman IH,Stamler JS,Hare JM.Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function.Proc Natl Acad Sci USA. 2012;109:4314-19.
59. Sengupta R,Ryter SW,Zuckerbraun BS,Tzeng E,Billiar TR,Stoyanovsky DA.Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols.Biochemistry. 2007;46:8472-83.
60. Benhar M,Forrester MT,Stamler JS.Protein denitrosylation: enzymatic mechanisms and cellular functions.Nat Rev Mol Cell Biol. 2009;10:721-32.
61. Melikian N,Seddon MD,Casadei B,Chowienczyk PJ,Shah AM.Neuronal nitric oxide synthase and human vascular regulation.Trends Cardiovasc Med. 2009;19:256-62.
62. Pagliaro P.Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO.Life Sci. 2003;73:2137-49.
63. Hofmann F,Feil R,Kleppisch T,Schlossmann J.Function of cGMP-dependent protein kinases as revealed by gene deletion.Physiol Rev. 2006;86:1-23.
64. Foster DB,Van Eyk JE,Marbán E,O'Rourke B.Redox signaling and protein phosphorylation in mitochondria: progress and prospects.J Bioenerg Biomembr. 2009;41:159-68.
65. Murphy E,Kohr M,Sun J,Nguyen T,Steenbergen C.S-nitrosylation: a radical way to protect the heart.J Mol Cell Cardiol. 2012;52:568-77.
66. Liu X,Miller MJS,Joshi MS,Thomas DD,Lancaster JR.Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes.Proc Natl Acad Sci USA. 1998;95:2175-9.
67. Nedospasov A,Rafikov R,Beda N,Nudler E.An autocatalytic mechanism of protein nitrosylation.Proc Natl Acad Sci USA. 2000;97:13543-8.
68. Burwell LS,Brookes PS.Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury.Antioxid Redox Signal. 2008;10:579-99.
69. Pacher P,Beckman JS,Liaudet L.Nitric oxide and peroxynitrite in health and disease.Physiol Rev. 2007;87:315-424.
70. Ischiropoulos H.Protein tyrosine nitration-An update.Arch Biochem Biophys. 2009;484:117-21.
71. Ferdinandy P,Schulz R.Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.Br J Pharmacol. 2003;138:532-43.
72. Edinger AL,Thompson CB.Death by design: apoptosis, necrosis and autophagy.Curr Opin Cell Biol. 2004;16:663-9.
73. Gottlieb RA,Finley KD,Mentzer RM.Cardioprotection requires taking out the trash.Basic Res Cardiol. 2009;104:169-80.
74. Giricz Z,Görbe A,Pipis J,Burley DS,Ferdinandy P,Baxter GF.Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats.Br J Pharmacol. 2009;158:1495-502.
75. Kohr MJ,Aponte AM,Sun J,Wang G,Murphy E,Gucek M,Steenbergen C.Characterization of potential S-nitrosylation sites in the myocardium.Am J Physiol Heart Circ Physiol. 2011;300:H1327-35.
76. Piantadosi CA.Regulation of mitochondrial processes by protein S- nitrosylation.Biochim Biophys Acta. 2012;1820:712-21.
77. Baba SP,Wetzelberger K,Hoetker JD,Bhatnagar A.Posttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation.Chem Biol Interact. 2009;178:250-8.
78. Lima B,Forrester MT,Hess DT,Stamler JS.S-nitrosylation in cardiovascular signaling.Circ Res. 2010;106:633-46.
79. Maron BA,Tang SS,Loscalzo J.S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system.Antioxid Redox Signal. 2013;18:270-87.
80. Aracena-Parks P,Goonasekera SA,Gilman CP,Dirksen RT,Hidalgo C,Hamilton SL.Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1.J Biol Chem. 2006;281:40354-68.
81. Gonzalez DR,Treuer AV,Castellanos J,Dulce RA,Hare JM.Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure.J Biol Chem. 2010;285:28938-45.
82. Eu JP,Sun J,Xu L,Stamler JS,Meissner G.The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions.Cell. 2000;102:499-509.
83. Adachi T,Weisbrod RM,Pimentel DR,Ying J,Sharov VS,Schöneich C,Cohen RA.S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide.Nat Med. 2004;10:1200-7.
84. Sun J,Picht E,Ginsburg KS,Bers DM,Steenbergen C,Murphy E.Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury.Circ Res. 2006;98:403-11.
85. Yoshida T,Inoue R,Morii T,Takahashi N,Yamamoto S,Hara Y,Tominaga M,Shimizu S,Sato Y,Mori Y.Nitric oxide activates TRP channels by cysteine S-nitrosylation.Nat Chem Biol. 2006;2:596-607.
86. Asada K,Kurokawa J,Furukawa T.Redox-and calmodulin-dependent S-nitrosylation of the KCNQ1 channel.J Biol Chem. 2009;284:6014-20.
87. Lu XM,Lu M,Tompkins RG,Fischman AJ.Site-specific detection of S-nitrosylated PKB alpha/Akt1 from rat soleus muscle using CapLC-Q-TOF(micro) mass spectrometry.J Mass Spectrom. 2005;40:1140-8.
88. Kwak YD,Ma T,Diao S,Zhang X,Chen Y,Hsu J,Lipton SA,Masliah E,Xu H,Liao FF.NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration.Mol Neurodegener. 2010;5:49-49.
89. Linares-Palomino J,Husainy MA,Lai VK,Dickenson JM,Galiñanes M.Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury.J Physiol. 2010;588:2173-91.
90. Stamler JS.NO/redox disequilibrium in the failing heart and cardiovascular system.J Clin Invest. 2005;115:509-17.
91. Sun J,Steenbergen C,Murphy E.S-nitrosylation: NO-related redox signaling to protect against oxidative stress.Antioxid Redox Signal. 2006;8:1693-705.
92. Hare JM,Stamler JS.NO/redox disequilibrium in the failing heart and cardiovascular system.J Clin Invest. 2005;115:509-17.
93. Vinten-Johansen J,Granfeldt A,Mykytenko J,Undyala VV,Dong Y,Przyklenk K.The multidimensional physiological responses to postconditioning.Antioxid Redox Signal. 2011;14:791-810.
94. Hausenloy DJ,Erik Bøtker H,Condorelli G,Ferdinandy P,Garcia-Dorado D,Heusch G,Lecour S,van Laake LW,Madonna R,Ruiz-Meana M,Schulz R,Sluijter JP,Yellon DM,Ovize M.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Cardiovasc Res. 2013;98:7-27.
95. Penna C,Mancardi D,Rastaldo R,Pagliaro P.Cardioprotection: a radical view Free radicals in pre and postconditioning.Biochim Biophys Acta. 2009;1787:781-93.
96. Burgoyne JR,Eaton P.Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-adrenergic-like signaling.J Biol Chem. 2009;284:29260-8.
97. Li XD,Cheng YT,Yang YJ,Meng XM,Zhao JL,Zhang HT,Wu YJ,You SJ,Wu YL.PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.Microvasc Res. 2012;84:44-54.
98. Edwards HV,Scott JD,Baillie GS.PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects.Biochem Soc Trans. 2012;40:210-4.
99. Yang C,Talukder MA,Varadharaj S,Velayutham M,Zweier JL.Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.Cardiovasc Res. 2013;97:33-43.
100. Wetzelberger K,Baba SP,Thirunavukkarasu M,Ho YS,Maulik N,Barski OA,Conklin DJ,Bhatnagar A.Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.J Biol Chem. 2010;285:26135-48.
101. Chen Y-R,Chen C-L,Pfeiffer DR,Zweier JL.Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation.J Biol Chem. 2007;282:32640-54.
102. Downey JM,Cohen MV.Reducing infarct size in the setting of acute myocardial infarction.Prog Cardiovasc Dis. 2006;48:363-71.
103. Perrelli MG,Pagliaro P,Penna C.Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species.World J Cardiol. 2011;3:186-200.
104. Strasen J,Ritter O.Role of nNOS in cardiac ischemia-reperfusion injury.Trends Cardiovasc Med. 2011;21:58-63.
105. Crisafulli A,Melis F,Tocco F,Pittau G,Lorrai L,Gori T,Mancardi D,Concu A,Pagliaro P.Delayed preconditioning-mimetic actions of exercise or nitroglycerin do not affect haemodynamics and exercise performance in trained or sedentary individuals.J Sports Sci. 2007;25:1393-401.
106. Vinten-Johansen J,Zhao ZQ,Jiang R,Zatta AJ.Myocardial protection in reperfusion with postconditioning.Expert Rev Cardiovasc Ther. 2005;3:1035-45.
107. Zhao ZQ,Vinten-Johansen J.Postconditioning: reduction of reperfusion-induced injury.Cardiovasc Res. 2006;70:200-11.
108. Yang X,Cohen MV,Downey JM.Mechanism of cardioprotection by early ischemic preconditioning.Cardiovasc Drugs Ther. 2010;24:225-34.
109. Ovize M,Baxter GF,Di Lisa F,Ferdinandy P,Garcia-Dorado D,Hausenloy DJ,Heusch G,Vinten-Johansen J,Yellon DM,Schulz R,Working Group of Cellular Biology of Heart of European Society of Cardiology.Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Cardiovasc Res. 2010;87:406-23.
110. Siegfried MR,Erhardt J,Rider T,Ma XL,Lefer AM.Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.J Pharmacol Exp Ther. 1992;260:668-75.
111. Hill M,Takano H,Tang XL,Kodani E,Shirk G,Bolli R.Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance.Circulation. 2001;104:694-9.
112. Penna C,Alloatti G,Cappello S,Gattullo D,Berta G,Mognetti B,Losano G,Pagliaro P.Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.Am J Physiol Heart Circ Physiol. 2005;288:H2512-20.
113. Iliodromitis EK,Gaitanaki C,Lazou A,Aggeli IK,Gizas V,Bofilis E,Zoga A,Beis I,Kremastinos DT.Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning.Basic Res Cardiol. 2006;101:327-35.
114. Penna C,Settanni F,Tullio F,Trovato L,Pagliaro P,Alloatti G,Ghigo E,Granata R.GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.Endocrinology. 2013;154:1624-35.
115. Perrelli MG,Tullio F,Angotti C,Cerra MC,Angelone T,Tota B,Alloatti G,Penna C,Pagliaro P.Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.Pflugers Arch. 2013;465:1031-40.
116. Hausenloy DJ,Yellon DM.Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.Heart Fail Rev. 2007;12:217-34.
117. Cohen MV,Downey JM.Cardioprotection: spotlight on PKG.Br J Pharmacol. 2007;152:833-4.
118. Hausenloy DJ,Yellon DM.Preconditioning and postconditioning: new strategies for cardioprotection.Diabetes Obes Metab. 2008;10:451-9.
119. Hausenloy DJ.Signalling pathways in ischaemic postconditioning.Thromb Haemost. 2009;101:626-34.
120. Hausenloy DJ,Ong SB,Yellon DM.The mitochondrial permeability transition pores as a target for preconditioning and postconditioning.Basic Res Cardiol. 2009;104:189-202.
121. Lecour S.Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?.J Mol Cell Cardiol. 2009;47:32-40.
122. Lecour S.Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?.J Mol Cell Cardiol. 2009;46:607-9.
123. Mancardi D,Penna C,Merlino A,Del Soldato P,Wink DA,Pagliaro P.Physiological and pharmacological features of the novel gas-transmitter: hydrogen sulfide.Biochim Biophys Acta. 2009;1787:864-72.
124. Ozcan S,Andrali SS,Cantrell JE.Modulation of transcription factor function by O-GlcNAc modification.Biochim Biophys Acta. 2010;1799:353-64.
125. Feng X,Sun T,Bei Y,Ding S,Zheng W,Lu Y,Shen P.S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis.Sci Rep. 2013;3:1814-1814.
126. Filice E,Angelone T,De Francesco EM,Pellegrino D,Maggiolini M,Cerra MC.Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart.Cell Physiol Biochem. 2011;28:41-52.
127. Angelone T,Quintieri AM,Pasqua T,Gentile S,Tota B,Mahata SK,Cerra C.Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin.Am J Physiol Heart Circ Physiol. 2012;302:H431-42.
128. Inserte J,Ruiz-Meana M,Rodríguez-Sinovas A,Barba I,Garcia-Dorado D.Contribution of delayed intracellular pH recovery to ischemic postconditioning protection.Antioxid Redox Signal. 2011;14:923-39.
129. Sun J,Morgan M,Shen RF,Steenbergen C,Murphy E.Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetic and calcium transport.Circ Res. 2007;101:1155-63.
130. Murphy E,Steenbergen C.Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury.Cardiovasc Res. 2007;75:478-86.
131. Sun J,Kohr MJ,Nguyen T,Aponte AM,Connelly PS,Esfahani SG,Gucek M,Daniels MP,Steenbergen C,Murphy E.Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins.Antioxid Redox Signal. 2012;16:45-56.
132. Penna C,Bassino E,Alloatti G.Platelet activating factor: the good and the bad in the ischemic/reperfused heart.Exp Biol Med (Maywood). 2011;236:390-401.
133. Lotz C,Liem D,Ping P.New frontiers in myocardial protection: a systems biology approach.J Cardiovasc Pharmacol Ther. 2011;16:285-9.
134. Kohr MJ,Sun J,Aponte A,Wang G,Gucek M,Murphy E,Steenbergen C.Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/ reperfusion injury with resin-assisted capture.Circ Res. 2011;108:418-26.
135. Okazaki T,Otani H,Shimazu T,Yoshioka K,Fujita M,Katano T,Ito S,Iwasaka T.Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart.J Mol Cell Cardiol. 2011;50:534-44.
136. Lin J,Steenbergen C,Murphy E,Sun J.Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection.Circulation. 2009;120:245-54.
137. Sun J.Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning.Sheng Li Xue Bao. 2007;59:544-52.
138. Sawicki G,Jugdutt BI.Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine reperfused myocardial infarction.Proteomics. 2007;7:2100-10.
139. Murphy E,Steenbergen C.Cardioprotection in females: a role for nitric oxide and altered gene expression.Heart Fail Rev. 2007;12:293-300.
140. Asanuma H,Nakai K,Sanada S,Minamino T,Takashima S,Ogita H,Fujita M,Hirata A,Wakeno M,Takahama H,Kim J,Asakura M,Sakuma I,Kitabatake A,Hori M,Komamura K,Kitakaze M.S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts.J Mol Cell Cardiol. 2007;42:924-30.
141. Cai Z,Yan LJ.Protein oxidative modifications: beneficial roles in disease and health.J Biochem Pharmacol Res. 2013;1:15-26.
142. Murray CI,Chung HS,Uhrigshardt H,Van Eyk JE.Quantification of mitochondrial S-nitrosylation by CysTMT6 switch assay.Methods Mol Biol. 2013;1005:169-79.
143. Murray CI,Van Eyk JE.A twist on quantification: measuring the site occupancy of S-nitrosylation.Circ Res. 2012;111:1253-5.
144. Schulz R,Ferdinandy P.Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activation.Free Radic Biol Med. 2013;54:113-5.
145. Kohr MJ,Aponte A,Sun J,Gucek M,Steenbergen C,Murphy E.Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication.Circ Res. 2012;111:1308-12.
146. Hidalgo C,Donoso P,Carrasco MA.The ryanodine receptors Ca2+ release channels: cellular redox sensors?.IUBMB Life. 2005;57:315-22.
147. Lin YF,Raab-Graham K,Jan YN,Jan LY.NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection.Proc Natl Acad Sci USA. 2004;101:7799-804.
148. Andoh T,Lee SY,Chiueh CC.Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress.FASEB J. 2000;14:2144-6.
149. Penna C,Perrelli MG,Tullio F,Angotti C,Camporeale A,Poli V,Pagliaro P.Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE.Basic Res Cardiol. 2013;108:371-371.
150. Methner C,Lukowski R,Grube K,Loga F,Smith RA,Murphy MP,Hofmann F,Krieg T.Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G.Basic Res Cardiol. 2013;108:337-337.
151. Nadtochiy SM,Burwell LS,Brookes PS.Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury.J Mol Cell Cardiol. 2007;42:812-25.
152. Prime TA,Blaikie FH,Evans C,Nadtochiy SM,James AM,Dahm CC,Vitturi DA,Patel RP,Hiley CR,Abakumova I,Requejo R,Chouchani ET,Hurd TR,Garvey JF,Taylor CT,Brookes PS,Smith RA,Murphy MP.A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury.Proc Natl Acad Sci USA. 2009;106:10764-9.
153. Chouchani ET,Hurd TR,Nadtochiy SM,Brookes PS,Fearnley IM,Lilley KS,Smith RA,Murphy MP.Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation.Biochem J. 2010;430:49-59.
154. Sun J,Aponte AM,Kohr MJ,Tong G,Steenbergen C,Murphy E.Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling?.Free Radic Biol Med. 2013;54:105-12.
155. Barua A,Standen NB,Galiñanes M.Dual role of nNOS in ischemic injury and preconditioning.BMC Physiol. 2010;10:15-15.
156. Cohen MV,Yang X-M,Downey JM.Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct sparing strategies.Cardiovasc Res. 2006;70:231-9.
157. Guo Y,Li Q,Wu W-J,Tan W,Zhu X,Mu J,Bolli R.Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse.J Mol Cell Cardiol. 2008;44:496-501.
158. Oldenburg O,Qin Q,Krieg T,Yang X-M,Philipp S,Critz SD,Cohen MV,Downey JM.Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection.Am J Physiol. 2004;286:H468-76.
159. Bell RM,Yellon DM.The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.Cardiovasc Res. 2001;52:274-80.
160. Shiva S,Sack MN,Greer JJ,Duranski M,Ringwood LA,Burwell L,Wang X,MacArthur PH,Shoja A,Raghavachari N,Calvert JW,Brookes PS,Lefer DJ,Gladwin MT.Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer.J Exp Med. 2007;204:2089-102.
161. González DR,Fernández IC,Ordenes PP,Treuer AV,Eller G,Boric MP.Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility.Nitric Oxide. 2008;18:157-67.
162. Garlid KD,Costa AD,Quinlan CL,Pierre SV,Dos Santos P.Cardioprotective signaling to mitochondria.J Mol Cell Cardiol. 2009;46:858-66.
163. Quinlan CL,Costa AD,Costa CL,Pierre SV,Dos Santos P,Garlid KD.Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels.Am J Physiol Heart Circ Physiol. 2008;295:H953-61.
164. Tang Z,Scherer PE,Okamoto T,Song K,Chu C,Kohtz DS,Nishimoto I,Lodish HF,Lisanti MP.Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle.J Biol Chem. 1996;271:2255-61.
165. Penna C,Perrelli MG,Pagliaro P.Mitochondrial pathways, permeabilità transition pore, and redox signaling in cardioprotection: therapeutic implications.Antioxid Redox Signal. 2013;18:556-99.
166. Murphy E,Steenbergen C.Preconditioning: the mitochondrial connection.Annu Rev Physiol. 2007;69:51-67.
167. Krieg T,Liu Y,Rütz T,Methner C,Yang XM,Dost T,Felix SB,Stasch JP,Cohen MV,Downey JM.BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.Eur Heart J. 2009;30:1607-13.
168. Salloum FN,Das A,Samidurai A,Hoke NN,Chau VQ,Ockaili RA,Stasch JP,Kukreja RC.Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.Am J Physiol Heart Circ Physiol. 2012;302:H1347-54.
169. Radovits T,Korkmaz S,Miesel-Gröschel C,Seidel B,Stasch JP,Merkely B,Karck M,Szabó G.Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.Eur J Cardiothorac Surg. 2011;39:248-55.
170. Penna C,Cappello S,Mancardi D,Raimondo S,Rastaldo R,Gattullo D,Losano G,Pagliaro P.Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway.Basic Res Cardiol. 2006;101:168-79.
171. Inserte J,Barba I,Poncelas-Nozal M,Hernando V,Agulló L,Ruiz-Meana M,Garcia-Dorado D.cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion.J Mol Cell Cardiol. 2011;50:903-9.
172. Penna C,Pagliaro P,Rastaldo R,Di Pancrazio F,Lippe G,Gattullo D,Mancardi D,Samaja M,Losano G,Mavelli I.F0F1 ATP synthase activity is differently modulated by coronary reactive hyperemia before and after ischemic preconditioning in the goat.Am J Physiol Heart Circ Physiol. 2004;287:H2192-200.
173. Nguyen TT,Stevens MV,Kohr M,Steenbergen C,Sack MN,Murphy E.Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.J Biol Chem. 2011;286:40184-92.
174. Eu JP,Hare JM,Hess DT,Skaf M,Sun J,Cardenas-Navina I,Sun QA,Dewhirst M,Meissner G,Stamler JS.Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide.Proc Natl Acad Sci USA. 2003;100:15229-34.
175. Eu JP,Sun J,Xu L,Stamler JS,Meissner G.The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions.Cell. 2000;102:499-509.
176. Xu L,Eu JP,Meissner G,Stamler JS.Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.Science. 1998;279:234-37.
177. Steinberg SF.Oxidative stress and sarcomeric proteins.Circ Res. 2013;112:393-405.
178. Gonzalez DR,Treuer A,Sun QA,Stamler JS,Hare JM.S-Nitrosylation of cardiac ion channels.J Cardiovasc Pharmacol. 2009;54:188-95.
179. Garcia-Dorado D,Ruiz-Meana M,Inserte J,Rodriguez-Sinovas A,Piper HM.Calcium-mediated cell death during myocardial reperfusion.Cardiovasc Res. 2012;94:168-80.
180. Suko J,Drobny H,Hellmann G.Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings.Biochim Biophys Acta. 1999;1451:271-87.
181. Cheong E,Tumbev V,Abramson J,Salama G,Stoyanovsky DA.Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors.Cell Calcium. 2005;37:87-96.
182. Cheong E,Tumbev V,Stoyanovsky D,Salama G.Effects of pO(2) on the activation of skeletal muscle ryanodine receptors by NO, A cautionary note.Cell Calcium. 2005;38:481-8.
183. Hart JD,Dulhunty AF.Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding.J Membr Biol. 2000;173:227-336.
184. Sun J,Yamaguchi N,Xu L,Eu JP,Stamler JS,Meissner G.Regulation of the cardiac muscle ryanodine receptor by O2 tension and S-nitrosoglutathione.Biochemistry. 2008;47:13985-90.
185. Tocchetti CG,Wang W,Froehlich JP,Huke S,Aon MA,Wilson GM,Di Benedetto G,O'Rourke B,Gao WD,Wink DA,Toscano JP,Zaccolo M,Bers DM,Valdivia HH,Cheng H,Kass DA,Paolocci N.Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling.Circ Res. 2007;100:96-104.
186. Pagliaro P,Mancardi D,Rastaldo R,Penna C,Gattullo D,Miranda KM,Feelisch M,Wink DA,Kass DA,Paolocci N.Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning.Free Radic Biol Med. 2003;34:33-43.
187. Campbell DL,Stamler JS,Strauss HC.Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.J Gen Physiol. 1996;108:277-93.
188. Hu H,Chiamvimonvat N,Yamagishi T,Marban E.Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors.Circ Res. 1997;81:742-52.
189. Poteser M,Romanin C,Schreibmayer W,Mayer B,Groschner K.S-nitrosation controls gating and conductance of the alpha 1 subunit of class C L-type Ca(2+) channels.J Biol Chem. 2001;276:14797-803.
190. Leary PJ,Rajasekaran S,Morrison RR,Tuomanen EI,Chin TK,Hofmann PA.A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.Am J Physiol Heart Circ Physiol. 2008;294:H2775-84.
191. Del Monte F,Lebeche D,Guerrero JL,Tsuji T,Doye AA,Gwathmey JK,Hajjar RJ.Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.Proc Natl Acad Sci USA. 2004;101:5622-7.
192. Zucchi R,Ronca F,Ronca-Testoni S.Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection?.Pharmacol Ther. 2001;89:47-65.
193. Foster DB,O'Rourke B,Van Eyk JE.What can mitochondrial proteomics tell us about cardioprotection afforded by preconditioning?.Expert Rev Proteomics. 2008;5:633-6.
194. Galkin A,Moncada S.S-nitrosation of mitochondrial complex I depends on its structural conformation.J Biol Chem. 2007;282:37448-53.
195. Heusch G,Boengler K,Schulz R.Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection.Basic Res Cardiol. 2010;105:151-4.
196. Martin C,Schulz R,Post H,Boengler K,Kelm M,Kleinbongard P,Gres P,Skyschally A,Konietzka I,Heusch G.Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia.Cardiovasc Res. 2007;74:46-55.
197. Granfeldt A,Lefer DJ,Vinten-Johansen J.Protective ischemia in patients: preconditioning and postconditioning.Cardiovasc Res. 2009;83: 234-46.
198. Penna C,Rastaldo R,Mancardi D,Raimondo S,Cappello S,Gattullo D,Losano G,Pagliaro P.Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation.Basic Res Cardiol. 2006;101:180-9.
199. Zatta AJ,Kin H,Lee G,Wang N,Jiang R,Lust R,Reeves JG,Mykytenko J,Guyton RA,Zhao ZQ,Vinten-Johansen J.Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.Cardiovasc Res. 2006;70:315-24.
200. Kuno A,Critz SD,Cohen MV,Downey JM.Nicorandil opens mitochondrial K(ATP) channels not only directly but also through a NO-PKG-dependent pathway.Basic Res Cardiol. 2007;102:73-9.
201. Foster DB,Ho AS,Rucker J,Garlid AO,Chen L,Sidor A,Garlid KD,O'Rourke B.Mitochondrial ROMK channel is a molecular component of mitoK(ATP).Circ Res. 2012;111:446-54.
202. Saini HK,Machackova J,Dhalla NS.Role of reactive oxygen species in ischemic preconditioning of subcellular organelles in the heart.Antioxid Redox Signal. 2004;6:393-404.
203. Boengler K,Konietzka I,Buechert A,Heinen Y,Garcia-Dorado D,Heusch G,Schulz R.Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43.Am J Physiol Heart Circ Physiol. 2007;292:H1764-9.
204. Rodriguez-Sinovas A,Boengler K,Cabestrero A,Gres P,Morente M,Ruiz-Meana M,Konietzka I,Miró E,Totzeck A,Heusch G,Schulz R,Garcia-Dorado D.Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection.Circ Res. 2006;99:93-101.
205. Sánchez JA,Rodríguez-Sinovas A,Barba I,Miró-Casas E,Fernández-Sanz C,Ruiz-Meana M,Alburquerque-Béjar JJ,García-Dorado D.Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.Basic Res Cardiol. 2013;108:351-351.
206. Chouchani ET,Methner C,Nadtochiy SM,Logan A,Pell VR,Ding S,James AM,Cochemé HM,Reinhold J,Lilley KS,Partridge L,Fearnley IM,Robinson AJ,Hartley RC,Smith RA,Krieg T,Brookes PS,Murphy MP.Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.Nat Med. 2013;19:753-9.
207. James AM,Sharpley MS,Manas AR,Frerman FE,Hirst J,Smith RA,Murphy MP.Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases.J Biol Chem. 2007;282:14708-18.
208. Zima AV,Blatter LA.Redox regulation of cardiac calcium channels and transporters.Cardiovasc Res. 2006;71:310-21.
209. Schulman IH,Hare JM.Regulation of cardiovascular cellular processes by S-nitrosylation.Biochim Biophys Acta. 2012;1820:752-62.
210. Penna C,Mancardi D,Raimondo S,Geuna S,Pagliaro P.The paradigm of postconditioning to protect the heart.J Cell Mol Med. 2008;12:435-58.
211. Iliodromitis EK,Andreadou I,Prokovas E,Zoga A,Farmakis D,Fotopoulou T,Ioannidis K,Paraskevaidis IA,Kremastinos DT.Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation.Basic Res Cardiol. 2010;105:193-203.
212. Fan Q,Yang XC,Liu Y,Wang LF,Liu SH,Ge YG,Chen ML,Wang W,Zhang LK,Irwin MG,Xia Z.Postconditioning attenuates myocardial injury by reducing nitro oxidative stress in vivo in rats and in humans.Clin Sci (Lond). 2010;120:251-61.